Mylan was a global pharmaceutical company known for its commitment to providing affordable, high-quality medicines worldwide.

Specializing in generic and specialty drugs, Mylan offered over 7,500 products across 165 countries. In November 2020, Mylan merged with Pfizer’s Upjohn division to form Viatris, a new global healthcare company. Hardy Partnership full scope cost management services on Mylan’s Dublin Respiratory facility. This project required a number of detailed stakeholder workshops to define design, process and equipment requirements. We met the clients expectations in terms of the desired commercial outcomes by provide strong strategic procurement and supply chain advice coupled with tight budget control.